Key result
CardioMEMS is a permanently implanted device to monitor pulmonary artery pressure and enable adjustments in therapy to avert hospitalization in patients with advanced heart failure.
Discusses the balance between effectiveness and cost-effectiveness for the CardioMEMS device in advanced heart failure.
T he proliferation of costly therapies has led to an increased focus on value.In the treatment of patients with advanced heart failure (HF), one such expensive intervention, CardioMEMS (CardioMEMS Heart Failure System, St. Jude Medical Inc., Atlanta, Georgia), is a permanently implanted device to monitor pulmonary artery pressure and enable adjustments in therapy that could avert the need for hospitalization.CardioMEMS was tested in P U B L I S H E D B Y E L S E V I E R h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c h f . 2 0 1 6 . 0 2 . 0 0 1
No takes yet. Share an insight, caveat, or question.
Dhruva et al. (2016) conducted an editorial in advanced heart failure (HF). CardioMEMS was evaluated. CardioMEMS is a permanently implanted device to monitor pulmonary artery pressure and enable adjustments in therapy to avert hospitalization in patients with advanced heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: